Literature DB >> 18445644

Mechanisms of extrahepatic vasodilation in portal hypertension.

M Hennenberg1, J Trebicka, T Sauerbruch, J Heller.   

Abstract

In liver cirrhosis, abnormal persistent extrahepatic vasodilation leads to hyperdynamic circulatory dysfunction which essentially contributes to portal hypertension. Since portal hypertension is a major factor in the development of complications in cirrhosis, the mechanisms underlying this vasodilation are of paramount interest. Extensive studies performed in cirrhotic patients and animals revealed that this vasodilation is associated on the one hand with enhanced formation of vasodilators, and on the other hand with vascular hyporesponsiveness to vasoconstrictors. The latter phenomenon has been termed "vascular hypocontractility". It is caused by a combination of different mechanisms and factors described in this review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445644     DOI: 10.1136/gut.2007.144584

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  52 in total

1.  A pharmacodynamic model of portal hypertension in isolated perfused rat liver.

Authors:  Tao Zhang; Xue-Yan Xu; Hang Zhou; Xin Zhao; Meng Song; Tao-Tao Zhang; He Yin; Ting Li; Peng-Tao Li; Da-Yong Cai
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

2.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

3.  Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

Review 4.  Treatment and management of ascites and hepatorenal syndrome: an update.

Authors:  Kurt Lenz; Robert Buder; Lisbeth Kapun; Martin Voglmayr
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

Review 5.  Bile acids regulate cardiovascular function.

Authors:  Sandeep Khurana; Jean-Pierre Raufman; Thomas L Pallone
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

Review 6.  Hepatic hemodynamic changes during liver transplantation: a review.

Authors:  An-Chieh Feng; Hsiu-Lung Fan; Teng-Wei Chen; Chung-Bao Hsieh
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

Authors:  Michaela Granzow; Robert Schierwagen; Sabine Klein; Benita Kowallick; Sebastian Huss; Markus Linhart; Irela G Reza Mazar; Jan Görtzen; Annabelle Vogt; Frank A Schildberg; Maria A Gonzalez-Carmona; Alexandra Wojtalla; Benjamin Krämer; Jacob Nattermann; Sören V Siegmund; Nikos Werner; Dieter O Fürst; Wim Laleman; Percy Knolle; Vijay H Shah; Tilman Sauerbruch; Jonel Trebicka
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425

8.  Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3.

Authors:  Qingfeng Yu; Christian Gratzke; Yiming Wang; Annika Herlemann; Christian Maximilian Sterr; Beata Rutz; Anna Ciotkowska; Xiaolong Wang; Frank Strittmatter; Christian G Stief; Martin Hennenberg
Journal:  Br J Pharmacol       Date:  2018-04-29       Impact factor: 8.739

Review 9.  Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.

Authors:  Yasuko Iwakiri
Journal:  Liver Int       Date:  2011-07-05       Impact factor: 5.828

10.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.